Recommendations: Immunization (1)
Recommendations immunization in people with diabetes1 are summarized on two slides Slide 1 of 2 Influenza and pneumonia are common, preventable infectious diseases associated with high mortality and morbidity in the elderly and in people with chronic disease1 Although studies reporting the morbidity and mortality of influenza and pneumococcal pneumonia specifically in people with diabetes are limited, observational studies of patients with a variety of chronic illnesses, including diabetes, show that these conditions are associated with an increase in hospitalizations for influenza and its complications1 Safe and effective vaccines are available that can greatly reduce the risk of serious complications from these diseases1 Recommendations for the immunization of people with diabetes2 are summarized on this slide Annually provide an influenza vaccine to all diabetes patients ≥6 months of age (C) Administer pneumococcal polysaccharide vaccine to all diabetes patients ≥2 years of age; a one-time revaccination is recommended for individuals >64 years of age previously immunized when they were <65 years of age if the vaccine was administered >5 years ago; other indications for repeat vaccination include nephrotic syndrome, chronic renal disease, and other immunocompromised states, such as after transplantation (C)63References Smith SA, Poland GA. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 2000;23:95-108. American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care 2013;36(suppl 1):S28.